Published in J Clin Immunol on September 01, 2002
Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut (2007) 1.10
A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing (2006) 0.93
Life and death of lymphocytes: a role in immunesenescence. Immun Ageing (2005) 0.88
Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease. Therap Adv Gastroenterol (2010) 0.78
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease. Am J Physiol Gastrointest Liver Physiol (2010) 0.78
Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial. World J Gastroenterol (2015) 0.77
Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. World J Gastroenterol (2008) 0.75
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science (1999) 6.24
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 4.92
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (1993) 2.97
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today (1997) 2.52
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol (1986) 2.48
Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today (1997) 2.44
NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function. J Exp Med (1995) 2.43
Mouse NK1+ T cells. Curr Opin Immunol (1995) 2.35
Immune responses to dietary antigens: oral tolerance. Immunol Today (1998) 2.04
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology (1997) 2.00
Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med (1996) 1.91
T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol (1998) 1.89
Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med (1994) 1.60
Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol (2000) 1.59
Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. J Immunol (1998) 1.43
Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci U S A (1997) 1.37
Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology (1997) 1.35
IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol (1998) 1.33
Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes. J Immunol (1993) 1.21
Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol (1999) 1.16
Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology (1997) 1.12
Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest (1996) 1.11
IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol (1996) 1.11
Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Hepatology (1999) 1.00
Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology (1999) 0.99
Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem (1996) 0.98
Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J Immunol (1997) 0.98
Strange brew: T cells in the liver. Immunol Today (1996) 0.97
RAG1, RAG2 and pre-T cell receptor alpha chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturation. Eur J Immunol (1996) 0.96
Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. Hepatology (1997) 0.95
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology (1998) 0.93
Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J Clin Invest (1996) 0.93
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest (1997) 0.93
Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. J Hepatol (2000) 0.79
Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease. Immunology (1998) 0.78
Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. Transplant Proc (2000) 0.75
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant (2006) 2.20
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol (2006) 2.19
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood (2002) 1.87
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol (2006) 1.86
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. J Hepatol (2011) 1.55
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol (2005) 1.24
Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J Pharmacol Exp Ther (2006) 1.16
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Am J Physiol Gastrointest Liver Physiol (2005) 1.03
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. Oncology (2004) 0.97
Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol (2002) 0.97
Retracted Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol (2007) 0.96
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Int J Cancer (2003) 0.96
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol Dis (2005) 0.96
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature. Liver Int (2004) 0.93
Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. J Gastroenterol Hepatol (2004) 0.92
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J (2007) 0.91
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Late cytomegalovirus disease following liver transplantation. Transpl Int (2003) 0.91
Glycolipids as immune modulatory tools. Mini Rev Med Chem (2006) 0.91
Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer (2005) 0.90
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol (2009) 0.90
Immunomodulation of experimental colitis via caloric restriction: role of Nk1.1+ T cells. Clin Immunol (2002) 0.90
Endocannabinoids and liver disease--review. Liver Int (2005) 0.89
The gut mucosa as a site for induction of regulatory T-cells. Curr Pharm Des (2009) 0.89
Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? Microbes Infect (2005) 0.88
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol (2005) 0.87
Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am J Physiol Endocrinol Metab (2008) 0.87
Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol (2008) 0.87
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin Immunol (2004) 0.86
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins. Am J Gastroenterol (2003) 0.85
Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J Leukoc Biol (2003) 0.84
The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence? J Am Acad Dermatol (2004) 0.83
beta-Glycosphingolipids as immune modulators. J Immunotoxicol (2008) 0.83
Enzyme replacement therapy for mild patients with Gaucher disease. Am J Hematol (2009) 0.83
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol (2007) 0.83
Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis. Inflamm Bowel Dis (2003) 0.82
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J Inflamm Res (2012) 0.82
Induction of immune tolerance: a role for Natural killer T lymphocytes? Liver Int (2005) 0.81
Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis. Mol Immunol (2008) 0.81
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial. Liver Int (2004) 0.81
A novel 13C-urea breath test device for the diagnosis of Helicobacter pylori infection: continuous online measurements allow for faster test results with high accuracy. J Clin Gastroenterol (2003) 0.81
Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J (2010) 0.81
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer (2002) 0.81
Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology. J Breath Res (2009) 0.80
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int J Cancer (2002) 0.80
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. J Lipid Res (2008) 0.80
Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models. Dig Dis Sci (2010) 0.80
Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol (2003) 0.80
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation (2004) 0.79
Air transportation of patients with end-stage liver disease to distant liver transplantation centers. Liver Transpl (2005) 0.79
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. Prostaglandins Leukot Essent Fatty Acids (2008) 0.79
Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease. Therap Adv Gastroenterol (2010) 0.78
NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. J Autoimmun (2008) 0.78
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial. J Clin Immunol (2015) 0.77
Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs. J Hepatol (2004) 0.77
Regulatory role of the pituitary-adrenal axis in experimental colitis: effect of adrenalectomy on the clinical course and the TH1/TH2 immune profile. Inflamm Bowel Dis (2005) 0.77
Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2. Am J Pathol (2009) 0.77
Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance induction. Microbes Infect (2003) 0.77
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial. World J Gastroenterol (2005) 0.77
Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking. Clin Immunol (2005) 0.77
Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats. J Gastroenterol Hepatol (2008) 0.77
Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells. J Dig Dis (2013) 0.77
Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. World J Gastroenterol (2007) 0.77
Decreased STAT-1 phosphorylation by a thio analogue of beta-D-glucosylceramide is associated with altered NKT lymphocyte polarization. Mol Immunol (2009) 0.77
Oral immune regulation: a new mode of therapy against chronic viral infections. Recent Pat Antiinfect Drug Discov (2007) 0.76
Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. Int Immunopharmacol (2008) 0.76
Towards a bank of cryopreserved hepatocytes: which cell to freeze? J Hepatol (2002) 0.75
Is presensitization relevant to liver transplantation outcome? Hum Immunol (2002) 0.75
Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. World J Gastroenterol (2008) 0.75
Impaired liver regeneration by β-glucosylceramide is associated with decreased fat accumulation. J Dig Dis (2013) 0.75
Idiopathic liver involvement in Turner syndrome. Isr Med Assoc J (2004) 0.75
Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection. Expert Rev Anti Infect Ther (2006) 0.75
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats. J Hepatol (2003) 0.75
Oral immune regulation: a novel method for modulation of anti-viral immunity. J Clin Virol (2004) 0.75
Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient. Isr Med Assoc J (2005) 0.75
[Idiopathic right-sided endocarditis: an uncommon manifestation of pulmonary cavitations]. Harefuah (2009) 0.75
Exacerbation of pulmonary sarcoidosis after liver transplantation. J Clin Gastroenterol (2002) 0.75
[Surgical intervention in infective endocarditis: indications and timing]. Harefuah (2005) 0.75
[Neurologic complications following liver transplantation]. Harefuah (2002) 0.75
Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. Digestion (2017) 0.75
[Hepatorenal syndrome: pathogenesis and treatment]. Harefuah (2007) 0.75